IMC Chicago’s Novavax NVAX Stock Holding History

IMC Chicago’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-78,083	Closed	-$708K	–	5882
2025 Q4	$525K	Buy	+78,083	New	+$589K	﹤0.01%	3443
2025 Q3	–	Sell	-61,793	Closed	-$481K	–	3793
2025 Q2	$389K	Buy	61,793 +17,329	+39%	+$115K	﹤0.01%	2995
2025 Q1	$285K	Buy	+44,464	New	+$368K	﹤0.01%	2950
2024 Q2	–	Sell	-68,322	Closed	-$687K	–	2730
2024 Q1	$327K	Buy	68,322 +16,671	+32%	+$77.3K	﹤0.01%	2209
2023 Q4	$248K	Buy	+51,651	New	+$316K	﹤0.01%	1773
2022 Q2	–	Sell	-41,853	Closed	-$2.17M	–	1118
2022 Q1	$3.08M	Buy	41,853 +5,212	+14%	+$465K	﹤0.01%	661
2021 Q4	$5.24M	Sell	36,641 -16,745	-31%	-$2.88M	﹤0.01%	609
2021 Q3	$11.1M	Buy	+53,386	New	+$11.8M	0.01%	475
2021 Q2	–	Sell	-14,087	Closed	-$2.58M	–	1166
2021 Q1	$2.55M	Buy	+14,087	New	+$2.81M	﹤0.01%	691
2020 Q3	–	Sell	-15,106	Closed	-$1.84M	–	991
2020 Q2	$1.26M	Buy	+15,106	New	+$578K	﹤0.01%	661

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IMC Chicago's NVAX Position: Q1 2026 in Review

IMC Chicago sold out of Novavax (NVAX) in Q1 2026, closing a stake of 78,083 shares — an estimated $708K sold.

IMC Chicago first reported a position in NVAX in Q2 2020 and held it in 10 quarters. The position peaked at $11.1M in Q3 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

IMC Chicago reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
IMC Chicago sold 78,083 Novavax shares in Q1 2026, an estimated $708K.
IMC Chicago first reported a position in Novavax in Q2 2020 and held it in 10 quarters.
IMC Chicago's Novavax position peaked at $11.1M in Q3 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.